Antibodies

ML Mingqun Lin
HL Hongyan Liu
QX Qingming Xiong
HN Hua Niu
ZC Zhihui Cheng
AY Akitsugu Yamamoto
YR Yasuko Rikihisa
request Request a Protocol
ask Ask a question
Favorite

Antibodies against A. phagocytophilum outer membrane protein P44 (mAb 5C11),124 dog anti-E. chaffeensis,122 rabbit anti-E. chaffeensis P28,52 ACT/actin (Sigma, A2066), Etf-1,43 BECN1 (Cell Signaling Technology, 3738), PIK3C3/VPS34 (Cell Signaling Technology, 4263), ATG5 (Abcam ab78073), MAP1LC3B/LC3B (NovusBio, NB100-2220), poly-ubiquitinated proteins (Enzo Life Sciences, FK1, BML-PW8805), mono- and poly-ubiquitinated proteins (Enzo Life Sciences, FK2, BML-PW8810), mouse anti-TUBA/α-tubulin (Santa Cruz Biotechnology, sc-5286), MYC/c-Myc (BioLegend, 901501), FLAG M2 (Sigma, F1804), RAB5,125 GFP (mAb Clone B-2; Santa Cruz Biotechnology, sc-9996), anti-VirB6-2,40 Alexa Fluor (AF) 350-conjugated goat anti-mouse IgG (Invitrogen, A-21049), AF555-conjugated goat anti-mouse IgG (Invitrogen, A-21427), and AF488-conjugated goat anti-rabbit IgG (Invitrogen, A-11008) or anti-mouse IgG (Invitrogen, A-11029) were used.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A